Propanc Biopharma Inc Forecast and Stock Analysis
Technical PPCB stock analysis for March 22, 2019.
No changes to the price of Propanc Biopharma Inc in the last trading day. The price has fallen in 5 of the last 10 days and is down by -13.75% for this period.
Close price at the end of the last trading day (Friday, 22nd Mar 2019) of the PPCB stock was $0.01.
During day the stock fluctuated 7.76% from a day low at $0.01 to a day high of $0.01.
30 day high of the PPCB stock price was $0.02 and low was $0.01.
90 day high was $0.03 and low was $0.01.
52 week high for the Propanc Biopharma Inc - $0.29 and low - $0.00.
Propanc Biopharma Inc lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -31.84% during the next 3 months and, with 90% probability hold a price between $0.01 and $0.01 at the end of this period.
A buy signal was issued from a pivot bottom point on Thursday March 21, 2019, which indicates further gains until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. Propanc Biopharma Inc holds sales signals from both short- and long-term moving averages. In addition, there is a general sales signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up there will be some resistance from the lines at $0.01 and $0.01. A break-up above any of these levels will issue buy signals. Volume fell on the last day without any changes to the price. This does not cause any direct divergence but may be an early warning and a possible "turning point". The very low volume increases the risk and reduces the other technical signals issued.
Relative Strength Index (RSI)
RSI14 is 31 and the stock is currently not being overbought or oversold
Support & Resistance
There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.
This stock may move much during a day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.00 between high and low, or 7.76%. For the last week the stock has had a daily average volatility of 14.69%.
Our recommended stoploss: We hold a sell evaluation for this stock. No stop-loss set.
Very Low Low Medium High Very High
Evaluation: Sell Candidate
Propanc Biopharma Inc holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.